Incidentally detected pancreatic neuroendocrine microadenoma with lymph node metastasis
Authors:
- 12 July 2018
- journal article
- research article
- Published by Springer Nature in Virchows Archiv
- Vol. 473 (5) , 649-653
Abstract
Pancreatic neuroendocrine microadenomas (NEMAs) are non-functioning neuroendocrine tumors < 0.5 cm with a low proliferation rate and are considered benign. We report on a pancreatic NEMA with lymph node metastasis. A male in his 70s had pylorus-preserving pancreaticoduodenectomy for a distal bile duct carcinoma, which was a 2.1 cm well-differentiated-infiltrating adenocarcinoma with invasion limited to the bile duct wall. An incidental separate 0.4 cm well-differentiated NEMA was found in the pancreatic head with metastatic well-differentiated neuroendocrine tumor in one peripancreatic lymph node. Both neuroendocrine tumors in the pancreatic head and in the lymph node were composed of nests of uniform neoplastic cells with a fine chromatin pattern. The Ki-67 labeling index of NEMA was 0.85%. The neoplastic neuroendocrine cells in both the pancreas and node were diffusely positive for synaptophysin, chromogranin, and insulin. Therefore, this unusual case provides an exception to the current classification system which regards NEMAs as benign lesions.Keywords
Funding Information
- National Research Foundation of Korea (2016R1A2B4009381)
- Asan Institute for Life Sciences, Asan Medical Center (2013–554)
- North American Neuroendocrine Tumor Society supported by the Neuroendocrine Tumor Research Foundation
- National Institutes of Health (CA62924)
This publication has 12 references indexed in Scilit:
- Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor SurvivalClinical Cancer Research, 2017
- Aberrant Menin expression is an early event in pancreatic neuroendocrine tumorigenesisHuman Pathology, 2016
- ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine TumorsNeuroendocrinology, 2016
- Clinicopathologic and Prognostic Significance of Multiple Hormone Expression in Pancreatic Neuroendocrine TumorsAmerican Journal of Surgical Pathology, 2015
- Alternative Lengthening of Telomeres Predicts Site of Origin in Neuroendocrine Tumor Liver MetastasesJournal of the American College of Surgeons, 2014
- Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine TumorsGastroenterology, 2014
- Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumorsLaboratory Investigation, 2012
- DAXX / ATRX , MEN1 , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine TumorsScience, 2011
- Primary Lymph Node Gastrinoma or Occult Duodenal Microgastrinoma With Lymph Node Metastases in a MEN1 PatientAmerican Journal of Surgical Pathology, 2008
- Clinical pathology of endocrine tumors of the pancreasDigestive Diseases and Sciences, 1991